A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...
Two institutes from Ethiopia and China have signed a memorandum of understanding (MoU) on scientific and technological c...
Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel antibiotic...
The biopharmaceutical company Mologen recently announced the signing of a license deal for the Chinese territory and a g...
China’s state-controlled drugmaker Harbin Pharmaceutical Group Holding Co plans to buy an about 40 percent st...
Industry veteran, Michael Glynn, has joined CANbridge Life Sciences' advisory team, where he will provide lead...
Healthcare investment firm Vivo Capital led the $55 million funding round of Beijing Innocare, a biopharmaceutical compa...
US based Biostage Inc., a biotechnology company developing bioengineered organ implants to treat life-threatening condit...
Tsinghua University Holdings (TUS) of Beijing is planning to invest $276 million to build a new biohub in the UK's Cambr...
American clinical stage biopharmaceutical company Rexahn Pharmaceuticals, Inc. has entered into collaboration with China...
Bangkok hosting Asia’s largest event ‘ProPak Asia’ which include the entire food, drink, and pharma pr...
Merck, a leading science and technology company, will celebrate its 350th anniversary this year with customers, partners...
Looking at China’s increasing zeal for improving biotechnology and medical services, the British government has ma...
China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...
China-US biopharma, Cellular Biomedicine recently announced a $30.6 million investment from Shanghai-Hong Kong PE invest...
ChineseInvestors.com, Inc., the premier financial information website for the Chinese-speaking investors, announced that...
Hong Kong Polytechnic University (PolyU) has announced a biotechnology and translational medicine collaboration program ...
Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharm...
